Back to search

National and Kapodistrian University of Athens

Ο προγνωστικός ρόλος της λιπονεκτίνης και της ρεζιστίνης σε ασθενείς με σταθερή στεφανιαία νόσο: μελέτη παρακολούθησης τεσσάρων ετών

Abstract

dc:description

Background and aims: Adiponectin has anti-atherogenic properties while resistin may promote atherosclerosis. However, studies investigating the role of adiponectin and resistin on clinical outcomes has led to conflicting results. We prospectively investigated the long-term prognostic value of adiponectin and resistin in patients with stable coronary artery disease (CAD) in the era of statins. Methods: A total of 776 consecutive patients with stable CAD were recruited and followed for a median of 5 years. Serum adiponectin, resistin, lipids, high-sensitivity C-reactive protein (hs-CRP), intereleukin-6 (IL-6) and homocysteine levels were measured. Primary endpoints were cardiovascular (CV) deaths and secondary endpoints hospitalizations for acute coronary syndrome (ACS), arrhythmic event or stroke. Results: Follow-up data were obtained from 713 patients of whom 79 had a CV death (11.1%) while 205 (28.8%) met the secondary endpoints. Five-hundred ninety-eight (83.9%) were on statins. Adiponectin was significantly positively correlated with hsCRP (r=0.075, p=0.037), IL-6 (r=0.107, p=0.018), and homocysteine (r=0.177, p <0.001). Resistin was significantly positively correlated with arterial hypertension (r=0.156, p <0.001), hs-CRP (r=0.167, p <0.001), IL-6 (r=0.161, p=0.002) and homocysteine (r=0.212, p <0.001). Adiponectin levels were independent predictors of CV death after adjustment for conventional risk factors for CAD (HR: 1.071; 95% CI: 1.040 - 1.104; p<0.001). Further adjustment for ejection fraction, hsCRP and statin treatment did not change the association (HR: 1.092; 95% CI: 1.053 - 1.133; p<0.001). Patients in the upper tertile of adiponectin (≥6.49 μg/mL) had 2.7 times higher risk of CV death compared to patients in the lower tertile (≤3.79 μg/mL) after adjustment for traditional risk factors for CAD (HR: 2.744; 95% CI: 1.542 - 4.882; p=0.001). The prognostic significance of resistin was not satistically significant for the occurrence of CV death (HR: 1.044; 95% CI: 0.994 – 1.096; p=0,087). Conclusions: Adiponectin but not resistin is an independent predictor of CV death in patients with stable CAD in the era of statins.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Katsimardos, Andreas
  • Κατσιμάρδος, Ανδρέας

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48902

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Katsimardos, Andreas; Κατσιμάρδος, Ανδρέας. Ο προγνωστικός ρόλος της λιπονεκτίνης και της ρεζιστίνης σε ασθενείς με σταθερή στεφανιαία νόσο: μελέτη παρακολούθησης τεσσάρων ετών. National and Kapodistrian University of Athens, 2021. http://hdl.handle.net/10442/hedi/48902